Global Immunofluorescence Assay Analyzers Market Insights and Forecast to 2028

Immunofluorescence assay analyzer can provide quantitative determination of all kinds of disease markers in human blood, urine and other body fluids.
Market Analysis and Insights: Global Immunofluorescence Assay Analyzers Market
Due to the COVID-19 pandemic, the global Immunofluorescence Assay Analyzers market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Enzyme-Linked Immunosorbent Assay accounting for % of the Immunofluorescence Assay Analyzers global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Hospitals and Diagnostic Centers segment is altered to an % CAGR throughout this forecast period.
China Immunofluorescence Assay Analyzers market size is valued at US$ million in 2021, while the US and Europe Immunofluorescence Assay Analyzers are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Immunofluorescence Assay Analyzers landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Immunofluorescence Assay Analyzers include PerkinElmer, BioMerieux, Inova Diagnostics, Getein Biotech, Lituo Biotechnology and Guangzhou Improve Medical Instruments, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Immunofluorescence Assay Analyzers Scope and Segment
Immunofluorescence Assay Analyzers market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Immunofluorescence Assay Analyzers market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Enzyme-Linked Immunosorbent Assay
Chemiluminescence Immunoassay
Radioimmunoassay
Enzyme Linked Fluorescent Immunoassay
Segment by Application
Hospitals and Diagnostic Centers
Pharmaceutical and Biotechnology Companies
Contract Research Organizations
Academic and Research Institutes
Others
By Company
PerkinElmer
BioMerieux
Inova Diagnostics
Getein Biotech
Lituo Biotechnology
Guangzhou Improve Medical Instruments
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E